Abstract:Background: Pulmonary hypertension increases perioperative risk in patients having mitral valve replacement, but most studies have included patients with mixed mitral valve disease and have not examined long-term outcome. Methods and results: We retrospectively examined the results and predictors of outcome of cardiac surgery in 43 patients (age, 62 +/- 13 years [mean +/- SD]; 81% women) with a primary diagnosis of mitral stenosis and severe pulmonary hypertension (pulmonary artery systolic pressure > or = 60 mm Hg or mean pressure > or = 50 mm Hg). Patients with more than mild mitral regurgitation were excluded. Thirty-eight patients (88%) were in NYHA functional class III or IV, and 11 patients (26%) had an acute presentation requiring urgent surgery. Preoperative hemodynamics demonstrated a mean mitral valve area of 0.7 +/- 0.3 cm2, mean pulmonary artery pressure of 50 +/- 9 mm Hg, and pulmonary artery systolic pressure of 81 +/- 18 mm Hg. Other characteristics included right ventricular failure (18 patients), coronary artery disease (16 patients), and critical aortic stenosis (11 patients). Forty patients underwent mitral valve replacement with St Jude prostheses; 3 had open commissurotomy. Additional surgical procedures included aortic valve replacement (42%), coronary artery bypass graft surgery (26%), and tricuspid valvuloplasty (16%). There were 5 perioperative deaths (11.6%), and 7 other patients (16%) had major complications, including reoperation for hemorrhage, stroke, respiratory failure, myocardial infarction, or a > 30-day hospitalization. Univariate analysis of demographic, hemodynamic, and operative characteristics identified the following predictors of perioperative death (P < .05): acute presentation, clinical evidence of right ventricular failure, impaired left ventricular ejection fraction, and increased left ventricular diastolic pressure. Predictors of complications (P < .05) were acute presentation, ECG evidence of right ventricular hypertrophy, and elevated right ventricular systolic pressure. Multivariate analysis showed only acute presentation and right ventricular hypertrophy as predictors of perioperative death or major complications, respectively. Five- and 10-year actuarial survivals were 80% and 64%, respectively. The only predictor of long-term mortality was advanced age. Functional NYHA status was improved by one grade or more in 76% of survivors. Conclusions: Patients referred to a tertiary care hospital in the United States with mitral stenosis and severe pulmonary hypertension often have other associated cardiac diseases and comorbid conditions. Cardiac surgery can be successfully performed with an acceptable mortality, and risk factors for poor perioperative outcome can be identified by preoperative clinical characteristics. Younger patients have the best long-term survival, and most survivors experienced long-term improvement in functional status.

High-risk mitral valve replacement in severe pulmonary hypertension--30 years experience

Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension

Mitral valve surgery in octogenarians: long-term and hemodynamic results

Long-term results of surgical treatment of secondary severe mitral regurgitation in patients with end-stage heart failure: Advantage of prosthesis insertion

Mid-term results of mitral valve replacement and repair: current clinical experience, technical aspects, and risk factor analysis

Mitral valve reconstruction and replacement for moderate to severe ischemic mitral regurgitation: comparison of midterm outcome and complications

P1755 Clinical and echocardiographic outcomes of mitral valve repair surgery

Mitral regurgitation surgery in heart failure due to ischemic cardiomyopathy: a 24-year experience

Early and late Results after Surgical Mitral Valve Repair: A High-Volume Center Experience

The Clinical and Hemodynamic Results of Mitral Balloon Valvuloplasty for Patients with Mitral Stenosis Complicated by Severe Pulmonary Hypertension

Pulmonary valve replacement—A 10-year single-center surgical experience in ACHD patients

Tissue versus mechanical mitral valve replacement in patients aged 50-70: a propensity-matched analysis

Late results of mitral valve repair for mitral regurgitation due to degenerative disease

Long-term Outcomes Following Repair or Replacement in Degenerative Mitral Valve Disease.

The effect of pulmonary hypertension and right ventricular dysfunction on early mortality and morbidity in patients undergoing mitral valve replacement

Mitral valve surgery for mitral regurgitation in patients with advanced dilated cardiomyopathy

Surgical Management of Severe Ischaemic Mitral Regurgitation

[Long-Term Results of Mitral-Aortic Valve Replacement in 1,154 Patients with Rheumatic Valvular Disease].

Long-term Follow-Up after Percutaneous Pulmonary Valve Implantation: Sustained Clinical Benefit with Evidence of Persistent Biventricular Reverse Remodeling and Improved Global Performance

Interim and long term results of percutaneous balloon mitral valvuloplasty

Midterm Outcome of Valve Repair for Rheumatic Mitral Stenosis: 6-year Experience in a Single Mid-Volume Cardiac Center